ATHE
Alterity Therapeutics Limited - American Depositary Shares (ATHE)
$42
About Alterity Therapeutics Limited - American Depositary Shares (ATHE)
Alterity Therapeutics Ltd. engages in the business of research and development of therapeutic drugs designed to treat neurodegenerative diseases, focusing on Parkinsonian and other movement disorders. Its lead candidate, ATH434, is an oral small molecule drug designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
Details
Daily high
$3.46
Daily low
$3.31
Price at open
$3.34
52 Week High
$5.89
52 Week Low
$2.66
Market cap
61.5M
Dividend yield
-
Volume
18,393
Avg. volume
21,024
P/E ratio
-3.56
Alterity Therapeutics Limited - American Depositary Shares News
Details
Daily high
$3.46
Daily low
$3.31
Price at open
$3.34
52 Week High
$5.89
52 Week Low
$2.66
Market cap
61.5M
Dividend yield
-
Volume
18,393
Avg. volume
21,024
P/E ratio
-3.56